{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:32:49Z","timestamp":1793082769150,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["AT010773"],"award-info":[{"award-number":["AT010773"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA048153"],"award-info":[{"award-number":["DA048153"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The cannabis plant produces many bioactive compounds, including the major cannabinoids THC and CBD, and many lesser studied \u201cminor\u201d phytocannabinoids including cannabinol (CBN), cannabichromene (CBC), cannabicyclol (CBL), and cannabigerol (CBG). These compounds are touted for various ailments, including pain, inflammation, and anxiety, but experimental data on their effects are lacking, especially that of CBL, which has yet to be assessed in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To assess in vivo activity, adult male and female C57BL\/6J mice were administered each compound and tested repeatedly in the tetrad battery. The potential analgesic effects in chronic pain states were assessed using the lipopolysaccharide (LPS)-induced hindpaw inflammatory pain and chronic constriction injury (CCI) neuropathic pain paradigms. Lastly, to address common psychological comorbidities of pain, CBN, CBL, and CBG were assessed in the tail suspension and marble burying tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Cannabinol (\u2265\u200925\u00a0mg\/kg) induced classic cannabinoid effects, including acute antinociception. These effects were differentially and partially blocked by selective antagonism of CB\n                      <jats:sub>1<\/jats:sub>\n                      , adenosine A\n                      <jats:sub>2A<\/jats:sub>\n                      , or TRPV1 receptors. CBL (\u2265\u200950\u00a0mg\/kg) induced hypothermia that was fully blocked by A\n                      <jats:sub>2A<\/jats:sub>\n                      antagonism but had no apparent CB\n                      <jats:sub>1<\/jats:sub>\n                      -mediated activity. LPS-induced edema and paw proinflammatory cytokine levels were reduced by either CBN or CBL (100\u00a0mg\/kg). CCI-induced cold allodynia was attenuated by either CBN (\u2265\u200950\u00a0mg\/kg) or CBL (100\u00a0mg\/kg), but only at high doses that also induce catalepsy and hypothermia. None of these minor cannabinoids displayed anxiolytic- or antidepressant-like activity without concomitant locomotor effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Together, these findings suggest that CBN produces anti-inflammatory effects via cannabinoid receptor-dependent and -independent pathways, whereas CBL acts primarily through CB receptor-independent mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-025-00384-7","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:23:19Z","timestamp":1770884599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anti-inflammatory and analgesic potential of minor cannabinoids in vivo"],"prefix":"10.1186","volume":"8","author":[{"given":"S. O.","family":"Vanegas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. F.","family":"Gamage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Maturano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sarlah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. G.","family":"Kinsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"384_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.phytochem.2015.04.007","volume":"117","author":"SA Ahmed","year":"2015","unstructured":"Ahmed SA, Ross SA, Slade D, Radwan MM, Khan IA, ElSohly MA. Minor oxygenated cannabinoids from high potency Cannabis sativa L. Phytochemistry. 2015;117:194\u20139. https:\/\/doi.org\/10.1016\/j.phytochem.2015.04.007.","journal-title":"Phytochemistry"},{"issue":"5\u20136","key":"384_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/10826076.2019.1701015","volume":"43","author":"RZ Al Bakain","year":"2020","unstructured":"Al Bakain RZ, Al-Degs YS, Cizdziel JV, Elsohly MA. Comprehensive classification of USA cannabis samples based on chemical profiles of major cannabinoids and terpenoids. J Liq Chromatogr Relat Technol. 2020;43(5\u20136):172\u201384. https:\/\/doi.org\/10.1080\/10826076.2019.1701015.","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"10","key":"384_CR3","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/cr.2011.60","volume":"21","author":"NAB Balenga","year":"2011","unstructured":"Balenga NAB, Aflaki E, Kargl J, Platzer W, Schr\u00f6der R, Bl\u00e4ttermann S, Kostenis E, Brown AJ, Heinemann A, Waldhoer M. GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils. Cell Res. 2011;21(10):1452\u201369. https:\/\/doi.org\/10.1038\/cr.2011.60.","journal-title":"Cell Res"},{"issue":"1","key":"384_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1744-8069-10-26","volume":"10","author":"RP Bonin","year":"2014","unstructured":"Bonin RP, Bories C, De Koninck Y. A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments. Mol Pain. 2014;10(1):1\u201310. https:\/\/doi.org\/10.1186\/1744-8069-10-26.","journal-title":"Mol Pain"},{"issue":"1\u20132","key":"384_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.drugalcdep.2009.06.009","volume":"105","author":"L Booker","year":"2009","unstructured":"Booker L, Naidu PS, Razdan RK, Mahadevan A, Lichtman AH. Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception. Drug Alcohol Depend. 2009;105(1\u20132):42\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.06.009.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"384_CR6","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","volume":"85","author":"F Borrelli","year":"2013","unstructured":"Borrelli F, Fasolino I, Romano B, Capasso R, Maiello F, Coppola D, et al. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol. 2013;85(9):1306\u201316. https:\/\/doi.org\/10.1016\/j.bcp.2013.01.017.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"384_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0014-2999(86)90051-8","volume":"126","author":"CL Broekkamp","year":"1986","unstructured":"Broekkamp CL, Rijk HW, Joly-Gelouin D, Lloyd KL. Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. Eur J Pharmacol. 1986;126(3):223\u20139. https:\/\/doi.org\/10.1016\/0014-2999(86)90051-8.","journal-title":"Eur J Pharmacol"},{"key":"384_CR8","doi-asserted-by":"publisher","unstructured":"Capozzi A, Caissutti D, Mattei V, Gado F, Martellucci S, Longo A, Recalchi S, Manganelli V, Riitano G, Garofalo T, Sorice M, Manera C, Misasi R. Anti-inflammatory activity of a cb2 selective cannabinoid receptor agonist: signaling and cytokines release in blood mononuclear cells. Molecules. 2022;27(1). https:\/\/doi.org\/10.3390\/molecules27010064.","DOI":"10.3390\/molecules27010064"},{"key":"384_CR9","doi-asserted-by":"publisher","DOI":"10.1055\/A-2320-8822\/ID\/RI0053-5\/BIB","author":"N Classen","year":"2024","unstructured":"Classen N, Pitakbut T, Sch\u00f6fb\u00e4nker M, K\u00fchn J, Hrincius ER, Ludwig S, et al. Cannabigerol and cannabicyclol block SARS-CoV-2 cell fusion. Planta Med. 2024. https:\/\/doi.org\/10.1055\/A-2320-8822\/ID\/RI0053-5\/BIB.","journal-title":"Planta Med"},{"key":"384_CR10","doi-asserted-by":"publisher","unstructured":"Cham, Switzerland Rock EM, Parker LA. Constituents of Cannabis Sativa. In: Murillo-Rodriguez E, Pandi-Perumal SR, Monti JM. (eds) Cannabinoids and Neuropsychiatric Disorders. Advances in Experimental Medicine and Biology, vol 1264. Springer, Cham. 2021.\u00a0 https:\/\/doi.org\/10.1007\/978-3-030-57369-0_1.","DOI":"10.1007\/978-3-030-57369-0_1"},{"issue":"1\u20133","key":"384_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","volume":"556","author":"B Costa","year":"2007","unstructured":"Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol. 2007;556(1\u20133):75\u201383. https:\/\/doi.org\/10.1016\/j.ejphar.2006.11.006.","journal-title":"Eur J Pharmacol"},{"key":"384_CR12","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1016\/s0040-4039(00)76346-5","volume":"55","author":"L Crombie","year":"1968","unstructured":"Crombie L, Ponsford R, Shani A, Yagnitinsky B, Mechoulam R. Hashish components. Photochemical production of cannabicyclol from cannabichromene. Tetrahedron Lett. 1968;55:5771\u20132. https:\/\/doi.org\/10.1016\/s0040-4039(00)76346-5.","journal-title":"Tetrahedron Lett"},{"key":"384_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ejphar.2017.05.006","volume":"807","author":"MS Crowe","year":"2017","unstructured":"Crowe MS, Kinsey SG. MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice. Eur J Pharmacol. 2017;807:198\u2013204. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.006.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"384_CR14","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/bph.13012","volume":"172","author":"MS Crowe","year":"2015","unstructured":"Crowe MS, Leishman E, Banks ML, Gujjar R, Mahadevan A, Bradshaw HB, et al. Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice. Br J Pharmacol. 2015;172(7):1700\u201312. https:\/\/doi.org\/10.1111\/bph.13012.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"384_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0306-3623(83)90004-6","volume":"14","author":"WM Davis","year":"1983","unstructured":"Davis WM, Hatoum NS. Neurobehavioral actions of cannabichromene and interactions with \u22069-tetrahydrocannabinol. Gen Pharmacol. 1983;14(2):247\u201352.","journal-title":"Gen Pharmacol"},{"issue":"7","key":"384_CR16","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","volume":"163","author":"L De Petrocellis","year":"2011","unstructured":"De Petrocellis L, Ligresti A, Moriello AS, Allar\u00e0 M, Bisogno T, Petrosino S, et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011;163(7):1479\u201394. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01166.x.","journal-title":"Br J Pharmacol"},{"issue":"1\u20132","key":"384_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.drugalcdep.2010.05.019","volume":"112","author":"GT DeLong","year":"2010","unstructured":"DeLong GT, Wolf CE, Poklis A, Lichtman AH. Pharmacological evaluation of the natural constituent of cannabis sativa, cannabichromene and its modulation by \u22069-tetrahydrocannabinol. Drug Alcohol Depend. 2010;112(1\u20132):126\u201333. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.05.019.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"384_CR18","doi-asserted-by":"publisher","first-page":"6075","DOI":"10.1021\/ACS.JOC.2C00336\/SUPPL_FILE\/JO2C00336_SI_001.PDF","volume":"87","author":"DG Dennis","year":"2022","unstructured":"Dennis DG, Anand SD, Lopez AJ, Petrov\u010di\u010d J, Das A, Sarlah D. Synthesis of the cannabimovone and cannabifuran class of minor phytocannabinoids and their anti-inflammatory activity. J Org Chem. 2022;87(9):6075\u201386. https:\/\/doi.org\/10.1021\/ACS.JOC.2C00336\/SUPPL_FILE\/JO2C00336_SI_001.PDF.","journal-title":"J Org Chem"},{"issue":"4","key":"384_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","volume":"95","author":"AT El-Alfy","year":"2010","unstructured":"El-Alfy AT, Ivey K, Robinson K, Ahmed S, Radwan M, Slade D, et al. Antidepressant-like effect of \u03949-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. Pharmacol Biochem Behav. 2010;95(4):434\u201342. https:\/\/doi.org\/10.1016\/j.pbb.2010.03.004.","journal-title":"Pharmacol Biochem Behav"},{"key":"384_CR20","doi-asserted-by":"publisher","unstructured":"ElSohly MA, Gul W. Constituents of cannabis sativa. In: Pertwee R, editor. Handbook of cannabis. Oxford University Press; 2014. pp. 3\u201322. https:\/\/doi.org\/10.1093\/acprof:oso\/9780199662685.003.0001.","DOI":"10.1093\/acprof:oso\/9780199662685.003.0001"},{"key":"384_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES28031164","author":"JM Ferraro","year":"2023","unstructured":"Ferraro JM, Umstead WJ. Chiral separation of cannabichromene, cannabicyclol, and their acidic analogs on polysaccharide chiral stationary phases. Molecules (Basel, Switzerland). 2023. https:\/\/doi.org\/10.3390\/MOLECULES28031164.","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"8","key":"384_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.imbio.2009.05.011","volume":"215","author":"DP Finn","year":"2010","unstructured":"Finn DP. Endocannabinoid-mediated modulation of stress responses: physiological and pathophysiological significance. Immunobiology. 2010;215(8):629\u201346. https:\/\/doi.org\/10.1016\/j.imbio.2009.05.011.","journal-title":"Immunobiology"},{"key":"384_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.pbb.2014.07.008","volume":"124","author":"TW Grim","year":"2014","unstructured":"Grim TW, Ghosh S, Hsu KL, Cravatt BF, Kinsey SG, Lichtman AH. Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models. Pharmacol Biochem Behav. 2014;124:405\u201311. https:\/\/doi.org\/10.1016\/j.pbb.2014.07.008.","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"384_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1515\/jbcpp-2015-0118","volume":"27","author":"TW Grim","year":"2016","unstructured":"Grim TW, Samano KL, Ignatowska-Jankowska B, Tao Q, Sim-Selly LJ, Selley DE, et al. Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497. J Basic Clin Physiol Pharmacol. 2016;27(3):217\u201328. https:\/\/doi.org\/10.1515\/jbcpp-2015-0118.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"384_CR25","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.2174\/0929867325666180313110254","volume":"25","author":"A Guerrero","year":"2018","unstructured":"Guerrero A. A2A adenosine receptor agonists and their potential therapeutic applications. An update. Curr Med Chem. 2018;25:3597\u2013612. https:\/\/doi.org\/10.2174\/0929867325666180313110254.","journal-title":"Curr Med Chem"},{"issue":"1","key":"384_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1021\/acs.jnatprod.4c00977","volume":"88","author":"M Haghdoost","year":"2025","unstructured":"Haghdoost M, DePorre Y, Figi M, Young S, Krebs C, Bonn-Miller MO. An unexpected activity of a minor cannabinoid: cannabicyclol (CBL) is a potent positive allosteric modulator of serotonin 5-HT1A receptor. J Nat Prod. 2025;88(1):58\u201366. https:\/\/doi.org\/10.1021\/acs.jnatprod.4c00977.","journal-title":"J Nat Prod"},{"key":"384_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ph17081010","author":"AM Jali","year":"2024","unstructured":"Jali AM, Banji D, Banji OJF, Hurubi KY, Tawhari FY, Alameer AA, et al. Navigating preclinical models and medications for peripheral neuropathy: a review. Pharmaceuticals. 2024. https:\/\/doi.org\/10.3390\/ph17081010.","journal-title":"Pharmaceuticals"},{"issue":"2\u20133","key":"384_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0304-3959(96)03068-0","volume":"66","author":"SA Kanaan","year":"1996","unstructured":"Kanaan SA, Saad\u00e9 NE, Haddad JJ, Abdelnoor AM, Atweh SF, Jabbur SJ, Safieh-Garabedian B. Endotoxin-induced local inflammation and hyperalgesia in rats and mice: A new model for inflammatory pain. Pain. 1996;66(2\u20133):373\u20139. https:\/\/doi.org\/10.1016\/0304-3959(96)03068-0.","journal-title":"Pain"},{"issue":"10","key":"384_CR29","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1021\/jo00184a024","volume":"49","author":"VV Kane","year":"1984","unstructured":"Kane VV, Martin AR, Peters JA. Carbon-13 nuclear magnetic resonance spectra of Cannabichromene, Cannabicitran, and Cannabicyclol and their analogues. J Org Chem. 1984;49(10):1793\u20136. https:\/\/pubs.acs.org\/sharingguidelines.","journal-title":"J Org Chem"},{"issue":"2","key":"384_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1124\/jpet.118.255661","volume":"371","author":"SW Kaski","year":"2019","unstructured":"Kaski SW, White AN, Gross JD, Trexler KR, Wix K, Harland AA, Prisinzano TE, Aub\u00e9 J, Kinsey SG, Kenakin T, Siderovski DP, Setola V. Preclinical testing of nalfurafine as an opioid-sparing adjuvant that potentiates analgesia by the mu opioid Receptor-targeting agonist morphine. J Pharmacol Exp Ther. 2019;371(2):487\u201399. https:\/\/doi.org\/10.1124\/jpet.118.255661.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20133","key":"384_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejphar.2013.06.001","volume":"715","author":"SG Kinsey","year":"2013","unstructured":"Kinsey SG, Cole EC. Acute \u22069-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice. Eur J Pharmacol. 2013;715(1\u20133):111\u20136. https:\/\/doi.org\/10.1016\/j.ejphar.2013.06.001.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"384_CR32","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1124\/jpet.109.155465","volume":"330","author":"SG Kinsey","year":"2009","unstructured":"Kinsey SG, Long JZ, O\u2019Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman AH. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J Pharmacol Exp Ther. 2009;330(3):902\u201310. https:\/\/doi.org\/10.1124\/jpet.109.155465.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"384_CR33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.pbb.2011.06.022","volume":"99","author":"SG Kinsey","year":"2011","unstructured":"Kinsey SG, Naidu PS, Cravatt BF, Dudley DT, Lichtman AH. Fatty acid amide hydrolase Blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice. Pharmacol Biochem Behav. 2011a;99(4):718\u201325. https:\/\/doi.org\/10.1016\/j.pbb.2011.06.022.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"384_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pbb.2010.12.002","volume":"98","author":"SG Kinsey","year":"2011","unstructured":"Kinsey SG, O\u2019Neal ST, Long JZ, Cravatt BF, Lichtman AH. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay. Pharmacol Biochem Behav. 2011b;98(1):21\u20137. https:\/\/doi.org\/10.1016\/j.pbb.2010.12.002.","journal-title":"Pharmacol Biochem Behav"},{"key":"384_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105895","author":"E Landucci","year":"2022","unstructured":"Landucci E, Mazzantini C, Lana D, Calvani M, Magni G, Giovannini MG, et al. Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model. Neurobiol Dis. 2022. https:\/\/doi.org\/10.1016\/j.nbd.2022.105895.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"384_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-87740-8","volume":"11","author":"JE LaVigne","year":"2021","unstructured":"LaVigne JE, Hecksel R, Keresztes A, Streicher JM. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Sci Rep. 2021;11(1):1\u201315. https:\/\/doi.org\/10.1038\/s41598-021-87740-8.","journal-title":"Sci Rep"},{"key":"384_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110134","author":"X Li","year":"2023","unstructured":"Li X, Zhang C, Tao H, Yang X, Qian X, Zhou J, et al. Dexmedetomidine alleviates osteoarthritis inflammation and pain through the CB2 pathway in rats. Int Immunopharmacol. 2023. https:\/\/doi.org\/10.1016\/j.intimp.2023.110134.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"384_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0376-8716(00)00205-2","volume":"63","author":"AH Lichtman","year":"2001","unstructured":"Lichtman AH, Poklis JL, Poklis A, Wilson DM, Martin BR. The pharmacological activity of inhalation exposure to marijuana smoke in mice. Drug Alcohol Depend. 2001;63(2):107\u201316. https:\/\/doi.org\/10.1016\/S0376-8716(00)00205-2.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"384_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nchembio.129","volume":"5","author":"JZ Long","year":"2009","unstructured":"Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol. 2009;5(1):37\u201344. https:\/\/doi.org\/10.1038\/nchembio.129.","journal-title":"Nat Chem Biol"},{"issue":"6","key":"384_CR40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/J.BPSC.2020.07.016","volume":"6","author":"HC Lu","year":"2021","unstructured":"Lu HC, Mackie K. Review of the endocannabinoid system. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6):607. https:\/\/doi.org\/10.1016\/J.BPSC.2020.07.016.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"3","key":"384_CR41","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/J.1476-5381.2010.01063.X","volume":"162","author":"S Maione","year":"2011","unstructured":"Maione S, Piscitelli F, Gatta L, Vita D, De Petrocellis L, Palazzo E, et al. Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action. Br J Pharmacol. 2011;162(3):584\u201396. https:\/\/doi.org\/10.1111\/J.1476-5381.2010.01063.X.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"384_CR42","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/sj.bjp.0706415","volume":"146","author":"R Mechoulam","year":"2005","unstructured":"Mechoulam R. Plant cannabinoids: a neglected pharmacological treasure trove. Br J Pharmacol. 2005;146(7):913\u20135. https:\/\/doi.org\/10.1038\/sj.bjp.0706415.","journal-title":"Br J Pharmacol"},{"key":"384_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1183019","author":"A Mendiguren","year":"2023","unstructured":"Mendiguren A, Aostri E, Rodilla I, Pujana I, Noskova E, Pineda J. Cannabigerol modulates \u03b12-adrenoceptor and 5-HT1A receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat. Front Pharmacol. 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1183019.","journal-title":"Front Pharmacol"},{"key":"384_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-3-319-45541-9_4","volume":"103","author":"P Morales","year":"2017","unstructured":"Morales P, Hurst DP, Reggio PH. Molecular targets of the phytocannabinoids-a complex picture. Prog Chem Org Nat Prod. 2017;103:103\u201331. https:\/\/doi.org\/10.1007\/978-3-319-45541-9_4.","journal-title":"Prog Chem Org Nat Prod"},{"key":"384_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/FNMOL.2018.00487","author":"C Muller","year":"2018","unstructured":"Muller C, Morales P, Reggio PH. Cannabinoid ligands targeting TRP channels. Front Mol Neurosci. 2018. https:\/\/doi.org\/10.3389\/FNMOL.2018.00487.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"384_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/S00213-006-0689-4","volume":"192","author":"PS Naidu","year":"2007","unstructured":"Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology. 2007;192(1):61\u201370. https:\/\/doi.org\/10.1007\/S00213-006-0689-4.","journal-title":"Psychopharmacology"},{"issue":"3","key":"384_CR47","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/can.2020.0177","volume":"6","author":"SR Nass","year":"2021","unstructured":"Nass SR, Steele FF, Ware TB, Libby AH, Hsu KL, Kinsey SG. Monoacylglycerol lipase inhibition using JZL184 attenuates paw inflammation and functional deficits in a mouse model of inflammatory arthritis. Cannabis Cannabinoid Res. 2021;6(3):233\u201341. https:\/\/doi.org\/10.1089\/can.2020.0177.","journal-title":"Cannabis Cannabinoid Res"},{"key":"384_CR48","unstructured":"National Research Council. Guide for the care and use of laboratory animals: eighth edition. Washington, DC: The National Academies Press;\u00a02011."},{"issue":"5","key":"384_CR49","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/bja\/aeq212","volume":"105","author":"TL Nguyen","year":"2010","unstructured":"Nguyen TL, Nam YS, Lee SY, Kim HC, Jang CG. Effects of capsazepine, a transient receptor potential vanilloid type 1 antagonist, on morphine-induced antinociception, tolerance, and dependence in mice. Br J Anaesth. 2010;105(5):668\u201374. https:\/\/doi.org\/10.1093\/bja\/aeq212.","journal-title":"Br J Anaesth"},{"issue":"17","key":"384_CR50","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1111\/BPH.15155","volume":"177","author":"B Palomares","year":"2020","unstructured":"Palomares B, Garrido-Rodriguez M, Gonzalo-Consuegra C, G\u00f3mez-Ca\u00f1as M, Saen-oon S, Soliva R, et al. \u22069-tetrahydrocannabinolic acid alleviates collagen\u2010induced arthritis: role of PPAR\u03b3 and CB1 receptors. Br J Pharmacol. 2020;177(17):4034. https:\/\/doi.org\/10.1111\/BPH.15155.","journal-title":"Br J Pharmacol"},{"key":"384_CR51","doi-asserted-by":"crossref","unstructured":"Pertwee RG, Cascio MG. Known Pharmacological actions of Delta-9-Tetrahydrocannabinoland of four other chemical constituents of cannabis that activate cannabinoid receptors. Handbook of cannabis: Oxford University Press; 2014. pp. 115\u201336.","DOI":"10.1093\/acprof:oso\/9780199662685.003.0006"},{"issue":"6","key":"384_CR52","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tins.2021.02.001","volume":"44","author":"KZ Peters","year":"2021","unstructured":"Peters KZ, Cheer JF, Tonini R. Modulating the neuromodulators: dopamine, serotonin, and the endocannabinoid system. Trends Neurosci. 2021;44(6):464\u201377. https:\/\/doi.org\/10.1016\/j.tins.2021.02.001.","journal-title":"Trends Neurosci"},{"issue":"1","key":"384_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0022-3565(25)32131-2","volume":"214","author":"MK Poddar","year":"1980","unstructured":"Poddar MK, Dewey WL. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes. J Pharmacol Exp Ther. 1980;214(1):63\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"384_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES26092774","author":"MM Radwan","year":"2021","unstructured":"Radwan MM, Chandra S, Gul S, Elsohly MA. Cannabinoids, phenolics, terpenes and alkaloids of cannabis. Molecules. 2021. https:\/\/doi.org\/10.3390\/MOLECULES26092774.","journal-title":"Molecules"},{"key":"384_CR55","doi-asserted-by":"publisher","unstructured":"Raup-Konsavage WM, Sepulveda DE, Wang J, Dokholyan NV, Vrana KE, Graziane NM. Antinociceptive effects of Cannabichromene (CBC) in mice: insights from von Frey, Tail-Flick, Formalin, and acetone tests. Biomedicines. 2024;12(1). https:\/\/doi.org\/10.3390\/biomedicines12010083.","DOI":"10.3390\/biomedicines12010083"},{"key":"384_CR56","doi-asserted-by":"crossref","unstructured":"Rhee M-H, Vogel Z, Barg J, Bayewitch M, Levy R, Hanu\u0161 L, Breuer A, Mechoulam R. Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase. 1997. https:\/\/pubs.acs.org\/sharingguidelines","DOI":"10.1021\/jm970126f"},{"key":"384_CR57","doi-asserted-by":"publisher","unstructured":"Rodriguez CEB, Vanegas SO, Reck AM, Schrom Y, Kinsey SG. Combined endocannabinoid and cyclooxygenase inhibition additively attenuates post-surgical pain. Cannabis Cannabinoid Res.\u00a02025;10(1):e101\u2013e111. https:\/\/doi.org\/10.1089\/can.2024.0088","DOI":"10.1089\/can.2024.0088"},{"key":"384_CR58","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ntt.2014.09.003","volume":"46","author":"S Rosenthaler","year":"2014","unstructured":"Rosenthaler S, P\u00f6hn B, Kolmanz C, Huu CN, Krewenka C, Huber A, Kranner B, Rausch W-D, Moldzio R. Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures. Neurotoxicol Teratol. 2014;46:49\u201356. https:\/\/doi.org\/10.1016\/j.ntt.2014.09.003.","journal-title":"Neurotoxicol Teratol"},{"key":"384_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/FPSYT.2021.643609\/FULL","volume":"12","author":"WH Roughan","year":"2021","unstructured":"Roughan WH, Campos AI, Garc\u00eda-Mar\u00edn LM, Cu\u00e9llar-Partida G, Lupton MK, Hickie IB, et al. Comorbid chronic pain and depression: shared risk factors and differential antidepressant effectiveness. Front Psychiatry. 2021;12:643609. https:\/\/doi.org\/10.3389\/FPSYT.2021.643609\/FULL.","journal-title":"Front Psychiatry"},{"issue":"5","key":"384_CR60","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1248\/bpb.34.774","volume":"34","author":"LR Ruhaak","year":"2011","unstructured":"Ruhaak LR, Felth J, Karlsson PC, Rafter JJ, Verpoorte R, Bohlin L. Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from cannabis sativa. Biol Pharm Bull. 2011;34(5):774\u20138. https:\/\/doi.org\/10.1248\/bpb.34.774.","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"384_CR61","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1208\/s12248-009-9110-7","volume":"11","author":"JE Schlosburg","year":"2009","unstructured":"Schlosburg JE, Carlson BLA, Ramesh D, Abdullah RA, Long JZ, Cravatt BF, Lichtman AH. Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice. AAPS J. 2009;11(2):342\u201352. https:\/\/doi.org\/10.1208\/s12248-009-9110-7.","journal-title":"AAPS J"},{"key":"384_CR62","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00213-011-2224-5","volume":"216","author":"JE Schlosburg","year":"2011","unstructured":"Schlosburg JE, O ST, Conrad DH, Lichtman AH. CB 1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action. Psychopharmacology. 2011;216:323\u201331. https:\/\/doi.org\/10.1007\/s00213-011-2224-5.","journal-title":"Psychopharmacology"},{"key":"384_CR63","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.124.002212","author":"AM Schwarz","year":"2024","unstructured":"Schwarz AM, Kobeci D, Mancuso J, Moreno-Rodriguez V, Seekins C, Bui T, et al. Select minor cannabinoids from cannabis sativa are cannabimimetic and antinociceptive in a mouse model of chronic neuropathic pain. J Pharmacol Exp Ther. 2024. https:\/\/doi.org\/10.1124\/jpet.124.002212.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"384_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13041-020-00721-2\/FIGURES\/3","volume":"14","author":"H Shoji","year":"2021","unstructured":"Shoji H, Miyakawa T. Effects of test experience, closed-arm wall color, and illumination level on behavior and plasma corticosterone response in an elevated plus maze in male C57BL\/6J mice: a challenge against conventional interpretation of the test. Mol Brain. 2021;14(1):1\u201312. https:\/\/doi.org\/10.1186\/S13041-020-00721-2\/FIGURES\/3.","journal-title":"Mol Brain"},{"key":"384_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/bf00428203","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 1985. https:\/\/doi.org\/10.1007\/bf00428203.","journal-title":"Psychopharmacology"},{"issue":"4","key":"384_CR66","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","volume":"90","author":"I Sv\u00ed\u017eensk\u00e1","year":"2008","unstructured":"Sv\u00ed\u017eensk\u00e1 I, Dubov\u00fd P, \u0160ulcov\u00e1 A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - a short review. Pharmacol Biochem Behav. 2008;90(4):501\u201311. https:\/\/doi.org\/10.1016\/j.pbb.2008.05.010.","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"384_CR67","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2131\/jts.39.711","volume":"39","author":"S Takeda","year":"2014","unstructured":"Takeda S, Okazaki H, Ikeda E, Abe S, Yoshioka Y, Watanabe K, et al. Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells. J Toxicol Sci. 2014;39(5):711\u20136. https:\/\/doi.org\/10.2131\/jts.39.711.","journal-title":"J Toxicol Sci"},{"issue":"5","key":"384_CR68","doi-asserted-by":"publisher","first-page":"139","DOI":"10.33696\/signaling.2.038.Effects","volume":"176","author":"Y Tang","year":"2018","unstructured":"Tang Y, Wolk B, Kendall DA. Effects of a CB2 subtype selective agonist ABK5-1 on cytokine production in microglia. Physiol Behav. 2018;176(5):139\u201348. https:\/\/doi.org\/10.33696\/signaling.2.038.Effects.","journal-title":"Physiol Behav"},{"issue":"2","key":"384_CR69","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","volume":"204","author":"A Thomas","year":"2009","unstructured":"Thomas A, Burant A, Bui N, Graham D, Yuva-Paylor LA, Paylor R. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology. 2009;204(2):361\u201373. https:\/\/doi.org\/10.1007\/s00213-009-1466-y.","journal-title":"Psychopharmacology"},{"key":"384_CR70","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.05.029","volume":"191","author":"KR Trexler","year":"2018","unstructured":"Trexler KR, Nass SR, Crowe MS, Gross JD, Jones MS, McKitrick AW, et al. Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice. Drug Alcohol Depend. 2018;191:14\u201324. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.05.029.","journal-title":"Drug Alcohol Depend"},{"key":"384_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108179","volume":"214","author":"KR Trexler","year":"2020","unstructured":"Trexler KR, Vanegas SO, Poklis JL, Kinsey SG. The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice. Drug Alcohol Depend. 2020;214:108179. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108179.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"384_CR72","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1124\/JPET.124.002189","volume":"391","author":"SO Vanegas","year":"2024","unstructured":"Vanegas SO, Zaki A, Dealy CN, Kinsey SG. The minor phytocannabinoid delta-8-tetrahydrocannabinol attenuates collagen-induced arthritic inflammation and pain-depressed behaviors. J Pharmacol Exp Ther. 2024;391(2):222\u201330. https:\/\/doi.org\/10.1124\/JPET.124.002189.","journal-title":"J Pharmacol Exp Ther"},{"key":"384_CR73","doi-asserted-by":"publisher","unstructured":"Vinall J, Pavlova M, Asmundson G, Rasic GJ, N., Noel M. children Mental Health Comorbidities in Pediatric Chronic Pain: A Narrative Review of Epidemiology, Models, Neurobiological Mechanisms and Treatment. 2016.\u00a0https:\/\/doi.org\/10.3390\/children3040040.","DOI":"10.3390\/children3040040"},{"issue":"3","key":"384_CR74","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1515\/jbcpp-2015-0080","volume":"27","author":"H Yang","year":"2016","unstructured":"Yang H, Zhou J, Lehmann C. GPR55 - A putative \u201ctype 3\u201d cannabinoid receptor in inflammation. J Basic Clin Physiol Pharmacol. 2016;27(3):297\u2013302. https:\/\/doi.org\/10.1515\/jbcpp-2015-0080.","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"12","key":"384_CR75","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1021\/OL401335U\/SUPPL_FILE\/OL401335U_SI_004.CIF","volume":"15","author":"HS Yeom","year":"2013","unstructured":"Yeom HS, Li H, Tang Y, Hsung RP. Total syntheses of cannabicyclol, clusiacyclol A and B, iso-eriobrucinol A and B, and eriobrucinol. Org Lett. 2013;15(12):3130\u20133. https:\/\/doi.org\/10.1021\/OL401335U\/SUPPL_FILE\/OL401335U_SI_004.CIF.","journal-title":"Org Lett"},{"issue":"1","key":"384_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-020-77175-Y","volume":"10","author":"A Zagzoog","year":"2020","unstructured":"Zagzoog A, Mohamed KA, Kim HJJ, Kim ED, Frank CS, Black T, et al. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Sci Rep. 2020;10(1):20405. https:\/\/doi.org\/10.1038\/S41598-020-77175-Y.","journal-title":"Sci Rep"},{"key":"384_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115289","author":"T Zikereya","year":"2025","unstructured":"Zikereya T, Liu C, Wei L, Wang Y, Zhang Z, Han C, et al. The cannabinoid receptor 1 mediates exercise-induced improvements of motor skill learning and performance in parkinsonian mouse. Exp Neurol. 2025. https:\/\/doi.org\/10.1016\/j.expneurol.2025.115289.","journal-title":"Exp Neurol"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-025-00384-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00384-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00384-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:08:43Z","timestamp":1781633323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42238-025-00384-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1186\/s42238-025-00384-7","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animals were maintained in accordance with guidelines published in the Guide for the Care and Use of Laboratory Animals (National Research Council,\n                      \n                      ). The Institutional Animal Care and Use Committee at the University of Connecticut approved all experimental protocols.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}